Sustained complete response of recurrent glioblastoma to combined checkpoint inhibition in a young patient with constitutional mismatch repair deficiency

MeSH terms

• Antineoplastic Agents, Immunological / therapeutic use*
• Brain Neoplasms / complications
• Brain Neoplasms / drug therapy*
• Brain Neoplasms / genetics
• Child, Preschool
• Colorectal Neoplasms / complications
• Glioblastoma / drug therapy*
• Glioblastoma / genetics
• Humans
• Ipilimumab / therapeutic use
• Male
• Neoplasm Recurrence, Local / drug therapy*
• Neoplasm Recurrence, Local / genetics
• Neoplastic Syndromes, Hereditary / complications
• Nivolumab / therapeutic use